Physician profile

Erin Murphy

Optometrist · Brecksville, OH

NPI 1245979608

$744.04

in general payments reported to CMS, 2019-2025

5 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$500.00
Food and Beverage$154.49

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Alcon Vision LLC $564.38 2022-2024 Precision 1
Coopervision INC. $86.49 2022-2024 Myday Contact Lens, Clariti Contact Lens
Bausch & Lomb Americas INC. $40.00 2023-2024 Infuse
Optos, INC. $30.77 2022
Abb Con-Cise Optical Group LLC $22.40 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Erin Murphy

$744.04

in general payments reported 2019-2025

Years
2022-2024
Top company
Alcon Vision LLC

https://glasscript.com/doctor/11339042/erin-murphy

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.